Results 61 to 70 of about 22,744 (213)

Prognostic Value of Magnetic Resonance Imaging Defined Extent of Surgical Resection in Dogs With Intracranial Meningiomas

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Surgery is a common treatment for intracranial meningiomas in dogs, although the prognostic impact of the extent of resection (EOR) has not been systematically evaluated. This retrospective study identified prognostic factors associated with clinical outcomes in dogs that underwent surgery and early post‐operative magnetic resonance imaging ...
John H. Rossmeisl   +6 more
wiley   +1 more source

The role of cytokines in ovarian cancer drug resistance

open access: yesInternational Journal of Cancer, Volume 158, Issue 4, Page 821-834, 15 February 2026.
Abstract Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients
Lu Wang   +7 more
wiley   +1 more source

Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials [PDF]

open access: yes, 2015
Background: To analyze the efficacy and toxicity of bevacizumab on survival outcomes in recurrent ovarian cancer. Results: Bevacizumab was associated with significant improvement of PFS and OS compared with standard treatment with HRs of 0.53 (95% CI 0.
BENEDETTI PANICI, PIERLUIGI   +9 more
core   +1 more source

Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer [PDF]

open access: bronze, 2023
Carmine Conte   +7 more
openalex   +1 more source

Neurological Involvement in Adult‐Onset Secondary Hemophagocytic Lymphohistiocytosis: Clinical Features and Prognostic Implications

open access: yesBrain and Behavior, Volume 16, Issue 2, February 2026.
This retrospective study showed that central nervous system (CNS) involvement in adult‐onset secondary hemophagocytic lymphohistiocytosis (sHLH) defines a severe phenotype and presented as an independent predictor of mortality. This study highlights the critical need for early neurological assessment and the development of CNS‐targeted treatment ...
Xue Wang   +3 more
wiley   +1 more source

Minimally invasive surgical treatment of recurrent endometrial carcinoma: A systematic review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 2, Page 866-878, February 2026.
Abstract Background While the role minimally invasive surgery (MIS) is established for primary endometrial carcinoma (EC), its feasibility in recurrent cases remains underexplored. Objective To systematically review the literature about MIS for EC recurrence.
Antonio Raffone   +12 more
wiley   +1 more source

Challenges in choice of the treatment strategy for patients with recurrent pseudomyxoma peritonei

open access: yesСибирский онкологический журнал, 2019
Pseudomixoma peritonei is a rare type of peritoneal carcinomatosis demonstrating an indolent course and a high rate of recurrence. primary surgical interventions in patients with pseudomixoma peritonei are extensive and traumatic, which worsens the ...
A. G. Abdullaev   +2 more
doaj   +3 more sources

Magnetic Resonance Imaging with Diffuse Weighted Imaging and Computed Tomography with Intravenous Contrast in Staging of Disseminated Ovarian, Stomach, Colorectal Cancer [PDF]

open access: yes, 2019
The aim of the research. Development and implementation of new methods for pre-operative staging of advanced ovarian, gastric and colorectal cancer to improve patient selection for cytoreductive surgery and increase its radicality.Materials and methods ...
Chetverikov, M. (Mykhailo)   +4 more
core  

Ovarian cancer [PDF]

open access: yes, 2016
Ovarian cancer is not a single disease and can be subdivided into at least five different histological subtypes that have different identifiable risk factors, cells of origin, molecular compositions, clinical features and treatments.
A Bashashati   +219 more
core   +1 more source

Home - About - Disclaimer - Privacy